BUB
CRL icon

BBVA USA Bancshares’s Charles River Laboratories CRL Stock Holding History

BBVA USA Bancshares’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.78M Buy
6,155
+244
+4% +$67.8K 0.08% 222
2020
Q4 		$1.48M Sell
5,911
-414
-7% -$98.6K 0.08% 236
2020
Q3 		$1.43M Sell
6,325
-297
-4% -$61.6K 0.08% 212
2020
Q2 		$1.15M Buy
6,622
+272
+4% +$43.4K 0.07% 234
2020
Q1 		$802K Buy
6,350
+696
+12% +$104K 0.06% 255
2019
Q4 		$863K Buy
+5,654
New +$783K 0.05% 289
2019
Q3 		– Sell
-5,692
Closed -$808K – 406
2019
Q2 		$808K Buy
5,692
+146
+3% +$19.8K 0.05% 291
2019
Q1 		$805K Buy
5,546
+166
+3% +$21.8K 0.05% 284
2018
Q4 		$609K Sell
5,380
-359
-6% -$44.9K 0.04% 307
2018
Q3 		$772K Sell
5,739
-38
-0.7% -$4.69K 0.05% 308
2018
Q2 		$648K Buy
5,777
+121
+2% +$13.1K 0.04% 320
2018
Q1 		$603K Buy
5,656
+118
+2% +$12.7K 0.04% 341
2017
Q4 		$607K Sell
5,538
-572
-9% -$62.2K 0.04% 341
2017
Q3 		$660K Buy
6,110
+106
+2% +$10.9K 0.04% 327
2017
Q2 		$607K Buy
6,004
+50
+0.8% +$4.6K 0.04% 339
2017
Q1 		$536K Buy
5,954
+285
+5% +$24.2K 0.04% 353
2016
Q4 		$431K Buy
5,669
+163
+3% +$12.4K 0.03% 385
2016
Q3 		$459K Buy
5,506
+2,025
+58% +$170K 0.03% 371
2016
Q2 		$287K Buy
+3,481
New +$287K 0.02% 445

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BBVA USA Bancshares's CRL Position: Q1 2021 in Review

BBVA USA Bancshares increased its Charles River Laboratories (CRL) stake by 4.1% in Q1 2021, buying an estimated $67.8K and bringing the position to 6,155 shares worth $1.78M. The position accounts for 0.08% of the portfolio, ranked #222.

BBVA USA Bancshares first reported a position in CRL in Q2 2016 and has held it in 19 quarters since. 562 funds tracked by Wall St. Rank hold CRL as of Q1 2021.

  • BBVA USA Bancshares held 6,155 shares of Charles River Laboratories worth $1.78M as of Q1 2021.
  • BBVA USA Bancshares bought 244 Charles River Laboratories shares in Q1 2021, an estimated $67.8K.
  • Charles River Laboratories made up 0.08% of BBVA USA Bancshares's portfolio in Q1 2021, its #222 holding.
  • BBVA USA Bancshares first reported a position in Charles River Laboratories in Q2 2016 and has held it in 19 quarters since.
  • 562 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.